Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DX2CTT
|
||||
| Drug Name |
(3-chloro-4-fluoro-benzyl)-(7,8-dimethoxy-10,11-dihydro-5H-2,4,5,11-tetraaza-dibenzo[a,d]cyclohepten-1-yl)-amine
|
||||
| Synonyms |
CHEMBL376089
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C20H19ClFN5O2
|
||||
| Canonical SMILES |
COc1cc2CNc3c(NCc4ccc(F)c(Cl)c4)ncnc3Nc2cc1OC
|
||||
| InChI |
InChI=1S/C20H19ClFN5O2/c1-28-16-6-12-9-23-18-19(24-8-11-3-4-14(22)13(21)5-11)25-10-26-20(18)27-15(12)7-17(16)29-2/h3-7,10,23H,8-9H2,1-2H3,(H2,24,25,26,27)
|
||||
| InChIKey |
UAMSEIYEHHABIH-UHFFFAOYSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Vascular endothelial growth factor receptor 2 | Target Info | [1587926] | ||
| Epidermal growth factor receptor III | Target Info | [1587926] | |||
| NetPath Pathway | IL2 Signaling Pathway | ||||
| PANTHER Pathway | Angiogenesis | ||||
| VEGF signaling pathway | |||||
| Pathway Interaction Database | HIF-2-alpha transcription factor network | ||||
| Beta3 integrin cell surface interactions | |||||
| Signaling events mediated by TCPTP | |||||
| SHP2 signaling | |||||
| S1P1 pathway | |||||
| VEGF and VEGFR signaling network | |||||
| Integrins in angiogenesis | |||||
| Signaling events mediated by VEGFR1 and VEGFR2 | |||||
| Notch-mediated HES/HEY network | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.